2oay
From Proteopedia
(New page: 200px<br /> <applet load="2oay" size="450" color="white" frame="true" align="right" spinBox="true" caption="2oay, resolution 2.35Å" /> '''Crystal structure o...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:2oay. | + | [[Image:2oay.jpg|left|200px]]<br /><applet load="2oay" size="350" color="white" frame="true" align="right" spinBox="true" |
| - | <applet load="2oay" size=" | + | |
caption="2oay, resolution 2.35Å" /> | caption="2oay, resolution 2.35Å" /> | ||
'''Crystal structure of latent human C1-inhibitor'''<br /> | '''Crystal structure of latent human C1-inhibitor'''<br /> | ||
| Line 6: | Line 5: | ||
==Overview== | ==Overview== | ||
C1 inhibitor, a member of the serpin family, is a major down-regulator of, inflammatory processes in blood. Genetic deficiency of C1 inhibitor, results in hereditary angioedema, a dominantly inheritable, potentially, lethal disease. Here we report the first crystal structure of the serpin, domain of human C1 inhibitor, representing a previously unreported latent, form, which explains functional consequences of several naturally, occurring mutations, two of which are discussed in detail. The presented, structure displays a novel conformation with a seven-stranded beta-sheet, A. The unique conformation of the C-terminal six residues suggests its, potential role as a barrier in the active-latent transition. On the basis, of surface charge pattern, heparin affinity measurements, and docking of a, heparin disaccharide, a heparin binding site is proposed in the contact, area of the serpin-proteinase encounter complex. We show how polyanions, change the activity of the C1 inhibitor by a novel "sandwich" mechanism, explaining earlier reaction kinetic and mutagenesis studies. These results, may help to improve therapeutic C1 inhibitor preparations used in the, treatment of hereditary angioedema, organ transplant rejection, and heart, attack. | C1 inhibitor, a member of the serpin family, is a major down-regulator of, inflammatory processes in blood. Genetic deficiency of C1 inhibitor, results in hereditary angioedema, a dominantly inheritable, potentially, lethal disease. Here we report the first crystal structure of the serpin, domain of human C1 inhibitor, representing a previously unreported latent, form, which explains functional consequences of several naturally, occurring mutations, two of which are discussed in detail. The presented, structure displays a novel conformation with a seven-stranded beta-sheet, A. The unique conformation of the C-terminal six residues suggests its, potential role as a barrier in the active-latent transition. On the basis, of surface charge pattern, heparin affinity measurements, and docking of a, heparin disaccharide, a heparin binding site is proposed in the contact, area of the serpin-proteinase encounter complex. We show how polyanions, change the activity of the C1 inhibitor by a novel "sandwich" mechanism, explaining earlier reaction kinetic and mutagenesis studies. These results, may help to improve therapeutic C1 inhibitor preparations used in the, treatment of hereditary angioedema, organ transplant rejection, and heart, attack. | ||
| - | |||
| - | ==Disease== | ||
| - | Known diseases associated with this structure: Angioedema, hereditary OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=606860 606860]] | ||
==About this Structure== | ==About this Structure== | ||
| - | 2OAY is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with NAG and GOL as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http:// | + | 2OAY is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=NAG:'>NAG</scene> and <scene name='pdbligand=GOL:'>GOL</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2OAY OCA]. |
==Reference== | ==Reference== | ||
| Line 25: | Line 21: | ||
[[Category: latent serpin; rcl insertion]] | [[Category: latent serpin; rcl insertion]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 14:14:30 2008'' |
Revision as of 12:14, 23 January 2008
|
Crystal structure of latent human C1-inhibitor
Overview
C1 inhibitor, a member of the serpin family, is a major down-regulator of, inflammatory processes in blood. Genetic deficiency of C1 inhibitor, results in hereditary angioedema, a dominantly inheritable, potentially, lethal disease. Here we report the first crystal structure of the serpin, domain of human C1 inhibitor, representing a previously unreported latent, form, which explains functional consequences of several naturally, occurring mutations, two of which are discussed in detail. The presented, structure displays a novel conformation with a seven-stranded beta-sheet, A. The unique conformation of the C-terminal six residues suggests its, potential role as a barrier in the active-latent transition. On the basis, of surface charge pattern, heparin affinity measurements, and docking of a, heparin disaccharide, a heparin binding site is proposed in the contact, area of the serpin-proteinase encounter complex. We show how polyanions, change the activity of the C1 inhibitor by a novel "sandwich" mechanism, explaining earlier reaction kinetic and mutagenesis studies. These results, may help to improve therapeutic C1 inhibitor preparations used in the, treatment of hereditary angioedema, organ transplant rejection, and heart, attack.
About this Structure
2OAY is a Single protein structure of sequence from Homo sapiens with and as ligands. Full crystallographic information is available from OCA.
Reference
C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease., Beinrohr L, Harmat V, Dobo J, Lorincz Z, Gal P, Zavodszky P, J Biol Chem. 2007 Jul 20;282(29):21100-9. Epub 2007 May 8. PMID:17488724
Page seeded by OCA on Wed Jan 23 14:14:30 2008
